{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:57Z","timestamp":1787032857994,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,4]]},"DOI":"10.7759\/cureus.81731","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T23:00:16Z","timestamp":1743807616000},"source":"Crossref","is-referenced-by-count":1,"title":["Drug-Induced Thrombotic Microangiopathy Arising During the Treatment of Anal Carcinoma After the Use of Mitomycin C"],"prefix":"10.7759","author":[{"given":"Krishna","family":"Sheth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith","family":"Saju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Obligado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Anal cancer","author":"Babiker HM","year":"2025","unstructured":"Babiker HM, Kashyap S, Mehta SR, Lekkala MR, Cagir BR. Anal cancer. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/27.2.115","article-title":"Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review","volume":"27","author":"Wu DC","year":"1997","unstructured":"Wu DC, Liu JM, Chen YM, Yang S, Liu SM, Chen LT, Whang-Peng J. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. Jpn J Clin Oncol. 1997, 27:115-8. 10.1093\/jjco\/27.2.115","journal-title":"Jpn J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29120760","article-title":"The nephrotoxicity of drugs used in causal oncological therapies","volume":"29","author":"Ha\u0142ka J","year":"2022","unstructured":"Ha\u0142ka J, Spaleniak S, Kade G, Antosiewicz S, Sigorski D. The nephrotoxicity of drugs used in causal oncological therapies. Curr Oncol. 2022, 29:9681-94. 10.3390\/curroncol29120760","journal-title":"Curr Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39347","article-title":"The prevalence and incidence of hemolytic uremic syndrome: a systematic review","volume":"15","author":"Aldharman SS","year":"2023","unstructured":"Aldharman SS, Almutairi SM, Alharbi AA, et al.. The prevalence and incidence of hemolytic uremic syndrome: a systematic review. Cureus. 2023, 15:e39347. 10.7759\/cureus.39347","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: a general approach to diagnosis and management","volume":"189","author":"Arnold DM","year":"2017","unstructured":"Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ. 2017, 189:E153-9. 10.1503\/cmaj.160142","journal-title":"CMAJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.05.023","article-title":"Quinine-induced thrombotic microangiopathy: a report of\u00a019\u00a0patients","volume":"70","author":"Page EE","year":"2017","unstructured":"Page EE, Little DJ, Vesely SK, George JN. Quinine-induced thrombotic microangiopathy: a report of\u00a019\u00a0patients. Am J Kidney Dis. 2017, 70:686-95. 10.1053\/j.ajkd.2017.05.023","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster RH","year":"2007","unstructured":"Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007, 357:580-7. 10.1056\/NEJMra066469","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1179\/1973947813Y.0000000122","article-title":"Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series","volume":"26","author":"Leal F","year":"2014","unstructured":"Leal F, Macedo LT, Carvalheira JB. Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series. J Chemother. 2014, 26:169-72. 10.1179\/1973947813Y.0000000122","journal-title":"J Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri ZL","year":"2015","unstructured":"Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015, 125:616-8. 10.1182\/blood-2014-11-611335","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23960","article-title":"Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin","volume":"90","author":"Reese JA","year":"2015","unstructured":"Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, George JN. Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015, 90:406-10. 10.1002\/ajh.23960","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.6.781","article-title":"Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry","volume":"7","author":"Lesesne JB","year":"1989","unstructured":"Lesesne JB, Rothschild N, Erickson B, et al.. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol. 1989, 7:781-9. 10.1200\/JCO.1989.7.6.781","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000000000061","article-title":"Chemotherapy-associated thrombotic microangiopathy","volume":"4","author":"Aklilu AM","year":"2023","unstructured":"Aklilu AM, Shirali AC. Chemotherapy-associated thrombotic microangiopathy. Kidney360. 2023, 4:409-22. 10.34067\/KID.0000000000000061","journal-title":"Kidney360"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre CM","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, et al.. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013, 368:2169-81. 10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000495031","article-title":"Treatment of chemotherapy-induced thrombotic microangiopathy with eculizumab in a patient with metastatic breast cancer","volume":"12","author":"Hausberg M","year":"2019","unstructured":"Hausberg M, Felten H, Pfeffer S. Treatment of chemotherapy-induced thrombotic microangiopathy with eculizumab in a patient with metastatic breast cancer. Case Rep Oncol. 2019, 12:1-6. 10.1159\/000495031","journal-title":"Case Rep Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13031","article-title":"A case of gemcitabine-induced thrombotic microangiopathy treated with ravulizumab in a patient with stage IV pancreatic cancer","volume":"13","author":"MacDougall KN","year":"2021","unstructured":"MacDougall KN, Schwartz B, Harewood J, Bukhari Z, Neculiseanu E. A case of gemcitabine-induced thrombotic microangiopathy treated with ravulizumab in a patient with stage IV pancreatic cancer. Cureus. 2021, 13:e13031. 10.7759\/cureus.13031","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330217-drug-induced-thrombotic-microangiopathy-arising-during-the-treatment-of-anal-carcinoma-after-the-use-of-mitomycin-c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T23:00:17Z","timestamp":1743807617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330217-drug-induced-thrombotic-microangiopathy-arising-during-the-treatment-of-anal-carcinoma-after-the-use-of-mitomycin-c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.81731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}